Providing market intelligence for more than 35 years

In The News

Gaming Consoles Still Top OTT Video Conduit

Of the platforms, Roku, which just launched a 4K-capable model, is now the third-most commonly used connected CE device for video streaming (10%), behind Microsoft’s Xbox (14%) and Sony’s PlayStation consoles (13%), Parks Associates said, noting that usage declined for both connected gaming consoles and DVRs, paired with a modest increase for smart TVs (see chart).

“Streaming media players continue to stake out a growing portion of the connected home,” said Barbara Kraus, director of research at Parks Associates, in a statement about the report -- The Streaming Media Device Landscape. “It is a rapid ascendance for streaming media players, and Roku in particular, especially considering the broad base of gaming console ownership compared to the lower penetration of streaming media devices.”

From the article "Gaming Consoles Still Top OTT Video Conduit" by Jeff Baumgartner.

Previously In The News

Samsung Leads in 4K TV Sales, Report Shows

Parks reported that 19 percent of U.S. broadband households intend to purchase a flat-panel TV set by the end of 2015. Roughly 40 percent of those households are looking for a 4K TV set, which is appr...

Cord Cutters Face A Sea Of Streaming Options

Hartstein’s decision was made easier because of a flood of Internet streaming services that allows consumers to cobble together their own video packages. There are more than 100 Internet video service...

Over Two-Thirds Of U.S. Smartphone Owners Stream Music Daily

A recent Parks Associates report reveals that 68 percent of U.S. smartphone owners listen to streaming music every day, for an average of 45 minutes per day. Amazon Prime Music emerged as the most pop...

Morning Read: Pharma Changes Afoot As Valeant Courts A New CEO And Novartis U.S. Head Exits

Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...